Balasubramanian S, Rho Gyu-Jin
Department of Animal Reproduction, Gynaecology and Obstetrics, Madras Veterinary College, Tamilnadu Veterinary and Animal Sciences University, Chennai 600007, Tamilnadu, India.
Anim Reprod Sci. 2007 Apr;98(3-4):282-92. doi: 10.1016/j.anireprosci.2006.03.011. Epub 2006 Apr 27.
In vitro techniques for production of bovine embryos including in vitro oocyte maturation (IVM), fertilization (IVF) and culture (IVC) are becoming increasingly employed for a variety of research purposes. However, decreased viability following cryopreservation by conventional methods has limited commercial applications of these technologies. A practical alternative to facilitate transport would be to arrest development by chilling without freezing. The present research was undertaken to evaluate chilling sensitivity of IVM-IVF embryos at different stages of development, and to determine possible beneficial effects of cysteamine treatment during IVM, previously shown to enhance embryo development in culture, on survival following chilling at different stages. Embryos produced by standard IVM-IVF-IVC methods were chilled to 0 degrees C for 30 min at 2-cell (30-34 h post-insemination, hpi), 8-cell (48-52 hpi) or blastocyst (166-170 hpi) stages. Viability after chilling was assessed by IVC with development to expanded blastocyst stage determined on days 7 and 8 post-insemination (pi) and hatching blastocyst stage determined on days 9 and 10 pi. Control embryos at the same stages were handled similarly, but without chilling, and development during culture similarly assessed. The effect of cysteamine supplementation (100 microM) of the IVM medium was determined for both chilled and non-chilled (control) embryos. Cysteamine supplementation during IVM had no significant effect on oocyte maturation or fertilization, but increased the proportions of oocytes developing to blastocyst stage by day 7 (13.7+/-0.9% versus 7.2+/-0.9%; P<0.05), total blastocysts (20.5+/-0.9% versus 15.3+/-1.3%; P<0.05), and hatching blastocysts (16.8+/-1.6% versus 12.0+/-1.5%; P<0.05). The greater survival in terms of hatching (78.6+/-7.0) following chilling of blastocysts produced by IVM-IVF of oocytes matured in media supplemented with cysteamine offers promise for applications requiring short-term storage to facilitate transport of in vitro produced bovine embryos.
用于生产牛胚胎的体外技术,包括体外卵母细胞成熟(IVM)、受精(IVF)和培养(IVC),正越来越多地用于各种研究目的。然而,传统方法冷冻保存后活力降低限制了这些技术的商业应用。一种便于运输的实用替代方法是通过冷藏而非冷冻来阻止发育。本研究旨在评估不同发育阶段的IVM-IVF胚胎的冷敏感性,并确定IVM期间半胱胺处理(先前已证明可增强培养中的胚胎发育)对不同阶段冷藏后存活的可能有益影响。通过标准IVM-IVF-IVC方法产生的胚胎在2细胞期(授精后30-34小时,hpi)、8细胞期(48-52 hpi)或囊胚期(166-170 hpi)被冷却至0℃30分钟。冷却后的活力通过IVC评估,在授精后(pi)第7天和第8天确定发育至扩张囊胚期,在第9天和第10天确定孵化囊胚期。相同阶段的对照胚胎以类似方式处理,但不进行冷却,并类似地评估培养期间的发育。确定了IVM培养基中添加半胱胺(100 microM)对冷却和未冷却(对照)胚胎的影响。IVM期间添加半胱胺对卵母细胞成熟或受精没有显著影响,但到第7天发育至囊胚期的卵母细胞比例增加(13.7±0.9%对7.2±0.9%;P<0.05),总囊胚比例增加(20.5±0.9%对15.3±1.3%;P<0.05),以及孵化囊胚比例增加(16.8±1.6%对12.0±1.5%;P<0.05)。在添加半胱胺的培养基中成熟的卵母细胞经IVM-IVF产生的囊胚在冷却后孵化方面具有更高的存活率(78.6±7.0),这为需要短期储存以便于运输体外生产的牛胚胎的应用提供了希望。